OPX Biotechnologies Appoints New Chief Technology Officer
BOULDER, CO – OPX Biotechnologies Inc. (OPXBIO), Boulder, CO, has appointed David Hogsett Vice President of Research and Development and Chief Technology Officer. Hogsett, who has extensive early-stage and commercial biotech company experience, will lead OPXBIO’s R&D team in using its proprietary EDGE™ (Efficiency Directed Genome Engineering) technology to make bio-based chemicals and fuels.
EDGE allows OPXBIO to quickly and efficiently develop advanced, economic bioprocesses using a wide range of feedstocks. OPXBIO’s sustainable chemicals and fuels can directly replace current petroleum-based products.